Targeted Mutation Testing

Targeted Mutation Testing is a molecular diagnostic method that belongs to the class of companion diagnostic assays, specifically designed to detect predefined genetic mutations in a patient's biomarker profile to determine eligibility for targeted therapeutic interventions.

61

Publications

5.1K

Citations

563

Authors

261

Institutions

Publications per year

2017–2026

24

Authors

563

  1. OF
    Olga Freylikhman

    Federal Almazov North-West Medical Research Centre, Russia

    2 publications · 92 citations

    2

    h-index

  2. ZM
    Zarghuna M.A. Shinwari

    King Faisal Specialist Hospital & Research Centre, Saudi Arabia

    2 publications · 72 citations

    2

    h-index

  3. MA
    Majid Al-Fayyadh

    King Faisal Specialist Hospital & Research Centre, Saudi Arabia

    2 publications · 72 citations

    2

    h-index

  4. XW
    Xintao Wu

    University of Arkansas at Fayetteville, United States

    2 publications · 28 citations

    2

    h-index

  5. AK
    Anna Kostareva

    Federal Almazov North-West Medical Research Centre, Russia

    2 publications · 92 citations

    2

    h-index

1–5 of 563

Venues

  1. Journal of Molecular Diagnostics

    JMD · 4 publications · 200 citations

    4

    h-index

  2. The Journal of Clinical Endocrinology & Metabolism

    JCEM · 2 publications · 231 citations

    2

    h-index

  3. Annals of Oncology

    2 publications · 55 citations

    2

    h-index

  4. 2

    h-index

  5. BioMed Research International

    2 publications · 47 citations

    2

    h-index

1–5